Loss of Surfacten® during bolus administration with a feeding catheter

Pediatr Int. 2017 Nov;59(11):1174-1177. doi: 10.1111/ped.13412.

Abstract

Background: Surfactant replacement therapy is widely used for treating neonatal respiratory distress syndrome, but insufficient evidence is available on the use of Surfacten® (S-TA). This study investigated the inadvertent loss of S-TA during instillation via feeding catheters with different bore sizes.

Methods: In this bench-based study, we measured the weight of syringes and tubes before and after surfactant treatment using a high-accuracy balance, and determined the amount of S-TA lost in tubes. We injected 120 mg of S-TA suspended in 4 or 3 mL into tubes followed with or without air boluses. Experiments were performed in triplicate. Percent weight loss of S-TA in each tube was calculated with or without air boluses.

Results: Percent weight loss of S-TA was significantly higher in larger-bore tubes (P < 0.01, overall ANOVA), and was significantly lower after air bolus flushing in 3 Fr, 4 Fr, and 5 Fr tubes (P < 0.005, respectively). The 3 mL S-TA suspensions had a significantly higher percent loss than the 4 mL S-TA suspensions when using 4 Fr and 5 Fr tubes, and the 5 Fr closed system (P < 0.05, respectively).

Conclusions: Routine air bolus flushing effectively reduces S-TA loss in tubes. The 3 mL S-TA suspensions appear to be more susceptible to inadvertent S-TA loss during instillation. Therefore, caution is warranted for this procedure.

Keywords: equipment design; instrumentation; intratracheal; intubation; surfactant.

MeSH terms

  • Biological Products / administration & dosage*
  • Enteral Nutrition / adverse effects*
  • Enteral Nutrition / methods
  • Equipment Design / adverse effects*
  • Humans
  • Infant, Newborn
  • Pulmonary Surfactants / administration & dosage*
  • Respiratory Distress Syndrome, Newborn / drug therapy*

Substances

  • Biological Products
  • Pulmonary Surfactants
  • beractant